动脉介入联合腹腔化疗治疗中晚期肝癌56例  被引量:4

Arterial catheterization plus general chemotherapy for 56 cases of middle or advanced hepatic carcinoma

在线阅读下载全文

作  者:赵增虎[1] 付显成[1] 刘秀芳[1] 李成云[1] 丁瑞亮[1] 

机构地区:[1]解放军251医院中医肿瘤科,河北张家口075000

出  处:《中国肿瘤临床与康复》2001年第4期86-87,共2页Chinese Journal of Clinical Oncology and Rehabilitation

摘  要:目的 为了探讨中、晚期肝癌行动脉介入联合腹腔化疗的疗效。方法  5 6例 (A组 )行动脉介入联合腹腔化疗 ,5 8例 (B组 )行动脉介入治疗。结果 A、B两组有效率分别为 6 4.3%、39.7%有显著差异 (P <0 .0 5 ) ,A组中位生存期明显延长 ,有 38例患者AFP下降明显 (P <0 .0 1)。结论 采用动脉介入联合腹腔化疗是治疗中、晚期肝癌有效方法之一 ,值得推广应用。Objective To explore the effect of arterial catheterization plus general chemotherapy on the treatment middle and advanced hepatic carcinoma.Methods 56 patients (group A) with middle or advanced hepatic carcinoma were treated by arterial catlheterization plus general chemotherapy.58 patients (group B) were treated by arterial catheterization.Results The response rate in group A and in group B was,64.3%, 39.7% respectively.The survival time in group A was significantly lengthened,and AFP decreased significantly in 38 cases.(P<0.01).Conclusion Arterial catheterization plus general chemotherapy is an effective method in treating middle and advanced liver carcinoma.

关 键 词:介入治疗 腹腔化疗 晚期 肝癌 

分 类 号:R735.7[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象